The strategy of this investment fund owner is to continue betting on innovative technology stocks of medium and small capitalization.
Cathie Wooddirector of ARK Invest, is an investment expert in tech stocks innovative mid- and small-cap companies that promise a disruptive impact on society.
Between December 6 and 11, the businesswoman acquired more than 676,000 shares of Tempus IA (TEM) for a value close to US$29.2 million.
This healthcare technology company was founded in 2015 and is dedicated to accurately diagnose through artificial intelligence. “The ability to deploy AI in precision medicine on a large scale has only recently become possible,” the company said in an SEC filing.
They added: “Advances in cloud computing, imaging technologies, large language models and low-cost molecular profiling, along with the digitization of large amounts of healthcare data, have created a landscape we believe is finally ripe for AI“.
Tempus IA went public in June 2024, with a public offering price of $37 per share, even though the company is already 10 years old. As soon as Cathie Wood did so, she began to increase her participation. The first acquisition was for more than US$9 million and added titles in September and October.
However, Tempus reported losses of $290 million and $214 million in 2022 and 2023, respectively. As for its shares, today they are listed at US$42, although they have accumulated a 16% drop in the last week and of almost 20% in the last 30 days.
Cathie Woods Fund Performance
Although the director of ARK Invest has many followers after the return she generated in 2020 of 153%, in the last three years it has not gone so well. Its flagship fund Ark Innovation (ARKK) has returned 18% so far this year, and -13.5% over the last three years.
In comparison, the S&P 500 It has a gain of almost 26% in 2024 and 10% in the last three years.
Source: Ambito
